Blueberries Medical has announced a non-brokered private placement consisting of the sale of 180,716,00 common shares at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1,987,876 (or approximately US$1,250,000) (the "Offering"). The net proceeds from the sale of the Common Shares will be used to repay existing debt and for general corporate and working capital purposes.
The Offering was led by Terraflos, a company with operations throughout Latin America founded and controlled by Facundo Garreton, who serves as the Chairman, CEO, and director of Blueberries. Terraflos is currently exploring various prospects in Argentina, Mexico, and Brazil and aims to expand its operations into those markets in the short term. The company's objective is to satisfy food and medicine needs in the near future using non-conventional methods without exploiting natural resources, as is common in current methodologies.